The cost of metastatic prostate cancer using time-driven activity-based costing.
Rafael José Vargas AlvesAna P Beck da Silva EtgesKatsuki Arima TiscoskiLuciana Rodrigues de LaraAlice de Medeiros ZelmanowiczCarisi Anne PolanczykPublished in: International journal of technology assessment in health care (2021)
This is the first study on the economic burden of mPC in the Brazilian PHS using the TDABC costing evaluation method. Accurate cost information obtained with the TDABC can be helpful in guiding disease management to guarantee better use of ever-scarcer resources.